[Comparative assessment of fluoroquinolones efficacy in the treatment of patients with infectious exacerbation of chronic obstructive bronchitis].
Moxyfloxacinum in a dose of 400 mg daily in tablets over 5 days proved to have good results in 92,7% of patients with infectious exacerbation of chronic obstructive bronchitis type I. Cyprofloxacin in a dose of 500 mg every 12 hours over 7 days had positive effects in 78,6%. Thus, the using of fluoroquinolones in patients with infectious exacerbation of chronic obstructive bronchitis type I gives sufficiently good results. It allows us to use Moxyfloxacinum as a drug of choice in treatment of patients with this disease.